Cargando…

Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies

The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their us...

Descripción completa

Detalles Bibliográficos
Autores principales: Si, Zhangyong, Zheng, Wenbin, Prananty, Dicky, Li, Jianghua, Koh, Chong Hui, Kang, En-Tang, Pethe, Kevin, Chan-Park, Mary B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729810/
https://www.ncbi.nlm.nih.gov/pubmed/35126968
http://dx.doi.org/10.1039/d1sc05835e
_version_ 1784627012145512448
author Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
author_facet Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
author_sort Si, Zhangyong
collection PubMed
description The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their usefulness. Cationic polymers, which target bacterial membranes, are thought to be the last frontier in antibacterial development. This class of molecules possesses several advantages including a low propensity for emergence of resistance and rapid bactericidal effect. This review surveys the structure–activity of advanced antimicrobial cationic polymers, including poly(α-amino acids), β-peptides, polycarbonates, star polymers and main-chain cationic polymers, with low toxicity and high selectivity to potentially become useful for real applications. Their uses as potentiating adjuvants to overcome bacterial membrane-related resistance mechanisms and as antibiofilm agents are also covered. The review is intended to provide valuable information for design and development of cationic polymers as antimicrobial and antibiofilm agents for translational applications.
format Online
Article
Text
id pubmed-8729810
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-87298102022-02-04 Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies Si, Zhangyong Zheng, Wenbin Prananty, Dicky Li, Jianghua Koh, Chong Hui Kang, En-Tang Pethe, Kevin Chan-Park, Mary B. Chem Sci Chemistry The growing prevalence of antimicrobial drug resistance in pathogenic bacteria is a critical threat to global health. Conventional antibiotics still play a crucial role in treating bacterial infections, but the emergence and spread of antibiotic-resistant micro-organisms are rapidly eroding their usefulness. Cationic polymers, which target bacterial membranes, are thought to be the last frontier in antibacterial development. This class of molecules possesses several advantages including a low propensity for emergence of resistance and rapid bactericidal effect. This review surveys the structure–activity of advanced antimicrobial cationic polymers, including poly(α-amino acids), β-peptides, polycarbonates, star polymers and main-chain cationic polymers, with low toxicity and high selectivity to potentially become useful for real applications. Their uses as potentiating adjuvants to overcome bacterial membrane-related resistance mechanisms and as antibiofilm agents are also covered. The review is intended to provide valuable information for design and development of cationic polymers as antimicrobial and antibiofilm agents for translational applications. The Royal Society of Chemistry 2021-12-16 /pmc/articles/PMC8729810/ /pubmed/35126968 http://dx.doi.org/10.1039/d1sc05835e Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Si, Zhangyong
Zheng, Wenbin
Prananty, Dicky
Li, Jianghua
Koh, Chong Hui
Kang, En-Tang
Pethe, Kevin
Chan-Park, Mary B.
Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_full Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_fullStr Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_full_unstemmed Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_short Polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
title_sort polymers as advanced antibacterial and antibiofilm agents for direct and combination therapies
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729810/
https://www.ncbi.nlm.nih.gov/pubmed/35126968
http://dx.doi.org/10.1039/d1sc05835e
work_keys_str_mv AT sizhangyong polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT zhengwenbin polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT pranantydicky polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT lijianghua polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT kohchonghui polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT kangentang polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT pethekevin polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies
AT chanparkmaryb polymersasadvancedantibacterialandantibiofilmagentsfordirectandcombinationtherapies